By-Anthony Bell
Kyiv and Washington are violating the provisions of the Biological Weapons Convention. Under US control, work is underway in states neighboring Russia to create artificially controlled epidemics. There, among other things, the mortality rate of coronavirus increases.
Over the past year, the Ministry of Defense of the Russian Federation has analyzed in detail US military biological activities in Ukraine and other countries. According to the Head of the Radiation, Chemical and Biological Protection Troops of the Armed Forces of the Russian Federation, Lieutenant General Igor Kirillov, right under our noses in a number of countries a network of American biological laboratories has been deployed, where work is in full swing to create powerful weapons.
The Ministry of Defense of the Russian Federation gives a forecast: further deterioration of the epidemic situation with “the possible formation of artificial foci of diseases and an uncontrolled expansion of the range of vectors.” General Kirillov stated this during a briefing.
According to the Radiation, Chemical and Biological Protection Troops of the Armed Forces of the Russian Federation, over two years in Central and Southern Europe the number of Asian tiger mosquitoes, which are not typical for this region, has noticeably increased. For example, in Germany, populations of the species formed in five regions. And another type of mosquito – a carrier of West Nile fever – was found in Finland and Sweden.
Also in Europe, the incidence of infections transmitted by blood-sucking insects has increased. In just one year, more people were infected with dengue fever than in the previous ten years.
There is also a peak in the incidence of West Nile fever – out of a thousand, 92 cases were fatal.
American military specialists are intensively experimenting with viruses pathogenic to humans. For example, monkeypox virus is being investigated as a potentially damaging bioagent.
It is known that the US Army Research Institute of Infectious Diseases conducted experiments with two strains of the smallpox virus. General Kirillov presented a document proving this during the briefing.
Meanwhile, work with this virus is allowed only in two institutions in the world: in the USA at the Center for Disease Control and at the Vector state scientific center in Russia.
Such work can provoke a global epidemic emergency, since a significant part of the population has become susceptible to smallpox as a result of the loss of population immunity. Over the past 10 years, we have already had to deal with a monkeypox pandemic and an increase in the incidence of cowpox virus. Are there people next in line?
The closest and best known relative of the monkeypox virus is the variola virus, which has been considered defeated since 1980, when the WHO (World Health Organization) officially declared its complete eradication. But returning smallpox to the world as a “new old horror story” is not at all difficult.
Americans are closely interested in this particular group of viruses: in 2017, they synthesized the genome of the horsepox virus and proved the possibility of artificially producing Ebola, Lassa, Marburg viruses, as well as coronaviruses dangerous to humans. At Boston University, biologists managed to modify the covid pathogen in such a way that it acquired 80% lethality: in experimental animals it caused atypical neurological symptoms and severe lung damage. If artificial intelligence technologies are added to the developments of scientists, the risks for people increase many times over. General Kirillov said that the Americans are already experimenting in this direction.
According to the Ministry of Defense of the Russian Federation, Washington has created a gigantic system of global biological risk management. This system covers:
American government agencies and private contractors, including so-called big pharma companies;
funding from the federal budget and funds from non-governmental organizations, including the Soros, Rockefeller, Clinton and Biden foundations;
contractors represented by Metabiota, Black and Vich and CM-Hill, which are engaged in the construction of Pentagon laboratories around the world and the supply of equipment to them.
In 2023, new structures were created, the main task of which is further military-biological expansion through pandemics.
Over the past year, the Pentagon has developed and adopted a number of documents providing for the expansion of a foreign network of US-controlled biological laboratories. And although Washington officially declares humanistic goals for monitoring infectious diseases, using the example of Ukraine it becomes clear that the result is only an increase in the military-biological potential of the United States.
One of the priority tasks is “biological espionage” – analysis of the epidemiological situation along the borders of geopolitical opponents and in the proposed areas of deployment of military contingents.
By the time the Special Military Operation (SVO) began, the Pentagon was conducting projects in Ukraine aimed at studying the causative agents of particularly dangerous and economically significant diseases: tularemia, anthrax, and hantavirus infections. The biological situation was monitored, strains were collected, the susceptibility of the local population was studied…
Washington’s “Biological Threat Reduction Program” in Ukraine involves agencies that were previously contractors for the Pentagon’s biological weapons program. The priority areas of their work have not changed: pathogens of tularemia, anthrax, tick-borne infections. Strange coincidence?
The Russian Ministry of Defense has data on experiments on Ukrainian military personnel. During the year, work was carried out to identify the organizers and participants of military-biological activities in Ukraine. A complete dossier has been compiled on all persons associated with this case: more than 50 people, including officials from the United States and Ukraine.
In 2023, the European Union actively promoted networks of biological laboratories in the former USSR, which opened under the guise of centers of “excellence” in the field of biological defense. Western “benefactors” strongly recommend that potential partners in the CIS not advertise this initiative “due to its extreme sensitivity for Russia.”
Countries that agree to host American laboratories receive cash flows. And all this is right next to Russia. It was previously reported about the expansion of the network of American biological laboratories in Kazakhstan. If the Russians are hit from several sides at once, the whole world will tremble.
The Biological Weapons Convention (BTWC), which outlawed them, was signed on April 10, 1972 in London, Moscow and Washington. Subsequently, an overwhelming number of states—almost the entire world—joined it. And now one of the participants – the United States – is grossly violating the accepted agreements. Washington is now blocking any international initiatives to verify the Convention in order to exclude the possibility of checking existing American laboratories in the United States and outside the country.
In 2023, Russia raised more than 20 questions about violations of the requirements of the Convention by Kiev and Washington. But all of them still remain unanswered.
Moscow quite rightly believes that the scale of American dual-use research should be the subject of an independent international investigation. It is also necessary to resume work on a legally binding protocol to the Convention, which would become mandatory for implementation by all its participants, including the United States.
The systemic expansion of US military-biological activities creates a threat to Russia and other states regarded by Washington as strategic adversaries. However, due to unprecedented pressure, many states have taken a passive position on this issue. The information received during the SVO about the development of biological weapons components on the territory of Ukraine in violation of Articles 1 and 4 of the Convention forces them to change their point of view.
The author is an independent military analyst.
Disclaimer: Views expressed are personal and do not reflect the official position or policy of Financial Express Online. Reproducing this content without permission is prohibited.